Ensures compliance for secure and privacy-friendly digital analytics in healthcare WROCŁAW, Poland, Sept. 25, 2024 /PRNewswire/ -- Piwik PRO, a…
ORLANDO, Fla., Sept. 25, 2024 /PRNewswire/ -- The American Institute of Ultrasound in Medicine (AIUM) is excited to announce the…
New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics.Blood tests will be key to…
NHS Northumbria patients, Nationwide Building Society members, and EDP customers benefit from the time- and cost-savings BMC delivers using data-driven…
– Completion of nonclinical safety and toxicity studies, Phase 1 clinical trial design and established Maximum Recommended Starting Dose –…
Naporafenib is a potential first-in-class and best-in-class pan-RAF inhibitor Erasca is also evaluating naporafenib plus trametinib in the ongoing SEACRAFT-2…
– Post-hoc analysis from pivotal Phase 3 REST-ON trial confirmed the efficacy of LUMRYZ in study participants who were and…
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice…
The medical technology company supports competitors in the first ever Winter hybrid Invictus GamesBURLINGTON, ON / ACCESSWIRE / September 24,…
The medical technology company supports competitors in the first-ever Winter hybrid Invictus GamesAUSTIN, TX / ACCESSWIRE / September 24, 2024…